Induced pluripotent stem cells (iPSCs) are widely regarded as a breakthrough in regenerative medicine and disease modeling. Their ability to proliferate indefinitely and differentiate into nearly any cell type makes them invaluable for drug screening, tissue repair, and personalized therapies. Yet, despite their promise, researchers continue to face significant challenges—particularly in...
For patients living with neurological disorders—stroke, traumatic brain injury, or spinal cord damage—the wait for effective therapies can feel endless. The reality is that developing a new drug can take more than a decade, with countless candidates failing along the way. Researchers are increasingly asking: how can we accelerate this process without compromising safety or...
Walk into any immunology lab today and you'll likely find researchers puzzling over the complement system. It's ancient, powerful, and sometimes unpredictable. For decades, scientists have known that complement proteins can protect us from infection—but they can also drive inflammation and autoimmune disease. The real challenge now is not just understanding what complement does, but how...
Flow cytometry has long been a cornerstone of biomedical research, enabling scientists to analyze thousands of cells in real time. From immune profiling to drug discovery, it provides a window into cellular diversity and function. Yet, as powerful as traditional cytometers are, they can be bulky, resource-intensive, and limited in flexibility. Enter microfluidics—a field that is quietly...
In recent years, gene therapy has emerged as one of the most promising frontiers in modern medicine. By addressing diseases at their genetic roots, researchers are opening doors to treatments that were once unimaginable. Two areas of innovation—circular RNA (circRNA) detection and AAV vector design for cystic fibrosis—highlight how advanced technologies are reshaping biomedical...
Immunotherapy has become one of the most dynamic areas in biomedical research. From CAR-T therapies to NK cell engineering, scientists are working to refine how immune cells can be harnessed against cancer. Yet, progress is not straightforward. Each step—from understanding immune clonality to overcoming tumor suppression and ensuring reliable manufacturing—presents its own...
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
